Clinical trial
A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for Correction of Lines and Wrinkles in the Cheek Area
NCT07344584 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for Correction of Lines and Wrinkles in the Cheek Area
- Lead sponsor
- Galderma R&D
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 17, 2026
- Completion date
- June 30, 2027
- Enrollment
- 60 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
wrinkle reduction